Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future Directions
We systematically reviewed published translational research on gene-based therapy for retinal ganglion cell (RGC) neuroprotection. A search was conducted on Entrez PubMed on 23 December 2020 using the keywords “gene therapy”, “retinal ganglion cell” and “neuroprotection. The initial search yielded 8...
Main Authors: | Jess Rhee, Kendrick Co Shih |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/4/581 |
Similar Items
-
Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
by: Stefania Vernazza, et al.
Published: (2021-07-01) -
Neuroprotection by Wld S depends on retinal ganglion cell type and age in glaucoma
by: Michael L. Risner, et al.
Published: (2021-06-01) -
Current approaches and advances in neuroprotection of glaucoma
by: Qian-Qian Hu, et al.
Published: (2014-04-01) -
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection
by: Tim J. Enz, et al.
Published: (2021-08-01) -
Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
by: Yubin Wang, et al.
Published: (2016-09-01)